EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer

被引：0
|
作者：
Roderich E. Schwarz
Niranjan Awasthi
Srivani Konduri
Danielle Cafasso
Margaret A. Schwarz
机构：
[1] UT Southwestern Medical Center,Department of Surgery, Division of Surgical Oncology
[2] UT Southwestern Medical Center,Department of Pediatrics, Division of Pediatric Critical Care Medicine
[3] The Cancer Institute of New Jersey,Department of Surgery, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Divisions of Surgical Oncology and Surgical Sciences
来源：
Annals of Surgical Oncology | 2010年 / 17卷
关键词：
Vascular Endothelial Growth Factor; Proliferate Cell Nuclear Antigen; PDAC Cell; ASPC Cell; Tumor Tissue Section;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1442 / 1452
页数：10
相关论文
共 50 条
  • [1] EMAP II-Based Antiangiogenic-Antiendothelial In Vivo Combination Therapy of Pancreatic Cancer
    Schwarz, Roderich E.
    Awasthi, Niranjan
    Konduri, Srivani
    Cafasso, Danielle
    Schwarz, Margaret A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (05) : 1442 - 1452
  • [2] In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II
    S. Konduri
    M. A. Schwarz
    R. E. Schwarz
    Annals of Surgical Oncology, 2004, 11 : S65 - S66
  • [3] In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II
    Konduri, S
    Schwarz, MA
    Schwarz, RE
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S65 - S66
  • [4] Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy
    Awasthi, Niranjan
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 571 - 582
  • [5] Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy
    Niranjan Awasthi
    Margaret A. Schwarz
    Roderich E. Schwarz
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 571 - 582
  • [6] An antiendothelial combination therapy strategy to increase survival in experimental pancreatic cancer
    Schwarz, Roderich E.
    Konduri, Srivani
    Awasthi, Niranjan
    Cafasso, Danielle
    Schwarz, Margaret A.
    SURGERY, 2009, 146 (02) : 241 - 249
  • [7] Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer
    Awasthi, Niranjan
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    CANCER BIOLOGY & THERAPY, 2010, 10 (01) : 99 - 107
  • [8] Augmenting chemotherapy response through EMAP II combination in experimental pancreatic cancer
    Awasthi, N.
    Schwarz, M. A.
    Yen, P. L.
    Schwarz, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [9] MHC class II-based colon cancer vaccine
    Xu, M
    Oiu, G
    von Hofe, E
    Humphreys, R
    FASEB JOURNAL, 2000, 14 (08): : A1355 - A1355
  • [10] Major histocompatibility complex Class II-based therapy for stroke
    Gonzales-Portillo, Bella M.
    Lee, Jea-Young
    Vandenbark, Arthur A.
    Offner, Halina
    Borlongan, Cesario, V
    BRAIN CIRCULATION, 2021, 7 (01) : 37 - 40
12345